Skip to content

Carlton M Kelly

2 papers in the library · 10 citations · publishing 2024-2026

Papers

Sort Most recent Most cited

Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression.

Journal of Affective Disorders June 4, 2026 Carlton M Kelly, Mathieu Fradet, Catherine Bostian et al.

Psilocybin has demonstrated promise for improving depressive symptoms in treatment-resistant depression, but its effects on anxiety, quality of life, functioning, and posttraumatic stress symptoms are less well studied. This study reports exploratory findings from an open-label trial in Veterans with TRD. Participants received a single 25-mg dose of psilocybin administered with psychological...

Psilocybin and hallucinogenic mushrooms.

CNS Spectrums December 1, 2024 Mathieu Fradet, Carlton M Kelly, Anna Donnelly et al. 10 citations

Psilocybin therapy has recently emerged as a promising new treatment for depression and other mental health disorders. This chapter summarizes the most recent data on its safety and efficacy. The delivery of psilocybin therapy and its subjective effects are also presented. Furthermore, this chapter outlines our current understanding of psilocybin's pharmacology and neurobiological effects....